Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones.
about
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancerThe non-genomic crosstalk between PPAR-gamma ligands and ERK1/2 in cancer cell linesIn vitro and in vivo cytotoxicity of troglitazone in pancreatic cancerInhibition of cell motility by troglitazone in human ovarian carcinoma cell line.Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.Troglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cellsIn vivo effects of rosiglitazone in a human neuroblastoma xenograft.Energy restriction as an antitumor target of thiazolidinediones.Positive regulations of adipogenesis by Italian ryegrass [Lolium multiflorum] in 3T3-L1 cells.Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5Troglitazone reduces glyoxalase I protein expression in glioma and potentiates the effects of chemotherapeutic agents.Topics in transcriptional control of lipid metabolism: from transcription factors to gene-promoter polymorphisms.Thiazolidinediones are partial agonists for the glucocorticoid receptor.The functional interaction between Acyl-CoA synthetase 4, 5-lipooxygenase and cyclooxygenase-2 controls tumor growth: a novel therapeutic target.Negative regulation of the oncogenic transcription factor FoxM1 by thiazolidinediones and mithramycin.Targeting PPARγ Signaling Cascade for the Prevention and Treatment of Prostate Cancer.Anaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options.Supporting a role for the GTPase Rab7 in prostate cancer progressionPPARgamma activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFbeta signalling.Anaplastic thyroid carcinomaEffect of troglitazone on radiation sensitivity in cervix cancer cells.The potential of antidiabetic thiazolidinediones for anticancer therapy.A Role for the PPARgamma in Cancer Therapy.The Role of PPAR-gamma and Its Interaction with COX-2 in Pancreatic Cancer.PPARgamma and Apoptosis in Cancer.A Novel Mechanism of PPARgamma Regulation of TGFbeta1: Implication in Cancer BiologyPPAR Ligands as Potential Modifiers of Breast Carcinoma Outcomes.Increasing doxorubicin activity against breast cancer cells using PPARγ-ligands and by exploiting circadian rhythmsCucurbitane Triterpenoid from Momordica charantia Induces Apoptosis and Autophagy in Breast Cancer Cells, in Part, through Peroxisome Proliferator-Activated Receptor γ Activation.Inflammation and lung carcinogenesis: applying findings in prevention and treatment.Thiazolidinediones as anti-cancer agents.Cellular fatty acid metabolism and cancerRetinoid and thiazolidinedione therapies in melanoma: an analysis of differential response based on nuclear hormone receptor expressionThiazolidinedione derivatives in diabetes and cardiovascular disease: an update.PPARgamma Inhibitors as Novel Tubulin-Targeting Agents.PPARgamma-independent antitumor effects of thiazolidinediones.PPAR Gamma Activators: Off-Target Against Glioma Cell Migration and Brain Invasion.Synergistic Antiproliferative Effects of Combined γ -Tocotrienol and PPAR γ Antagonist Treatment Are Mediated through PPAR γ -Independent Mechanisms in Breast Cancer Cells.Rosiglitazone regulates anti-inflammation and growth inhibition via PTEN.Peroxisome proliferator-activated receptor γ and colorectal cancer.
P2860
Q21328702-42FDBEFB-26E1-4F4B-A9CD-C00EC62ED841Q28238709-0BEC0AD5-03B9-404D-AFD7-A0E9AB8D6C88Q32174263-0CD5437D-1B84-4837-AB98-CCFD6E9B9C72Q33306169-C6DC05EF-7B0F-41D2-AA7C-2F52D5EAA9DDQ33318963-240893FC-C678-4521-A035-13F02BECD78CQ33637896-7D75934F-4423-47AE-9BAF-31F155E0B31FQ33723620-EA88A407-1BCA-4FA2-984B-72F426A1193DQ33744668-20DE1732-ADC4-484B-A0FD-9B03DFA67100Q33756167-96482A74-BE32-4370-B345-88182DFB34CEQ33761619-F8D52D56-1F8D-4981-B50E-989268894B44Q33829548-14986E00-96F3-4371-B35E-3BFC3ACD6CFFQ33879733-8A545938-896B-4FD6-9539-1C48170A5495Q33948063-FF9C2BCE-4877-4746-9E91-B477ED6AB9E0Q34342416-E6025982-31D0-4F26-BF8D-8EB6AD345C83Q34420463-3DA06B2A-71D2-4B89-A9F2-ACDC4A89244AQ34646050-B8457CA3-CBFF-4509-829F-1EB379A61D70Q35000792-6BDF60D6-2197-4874-9FB4-AA8F07EB8EA0Q35088284-509A1660-B578-448F-8868-05D5BF607E5BQ35458969-07D473FF-17D1-4D1B-9AD2-0B008EC8B66BQ36075843-2673ECCB-AD38-4448-B89E-2A19D2DBA697Q36195948-8E63B91A-748E-47D4-9692-D1F515B4A9C3Q36568732-B85C84F0-4817-4AB6-B5AC-F6AA90C46889Q36691611-4399624D-2B5B-497A-AB9E-5899ADACFEA3Q36742740-0A784E2F-CC96-44EE-9DF4-2A10387D9C8BQ36742811-ACF18D47-0647-4759-8B58-402720A668D2Q36743890-0B48393F-5B9E-4BC5-AAB8-4B0FE09A1F98Q36772391-FA28CA23-DE1B-4A6A-8256-9DCE99813139Q36965932-C92E42C0-4A03-4D28-9BE0-58C4D57A6C4EQ36969586-B97959D4-75F6-4A43-86E5-D14C2C912045Q36974700-B6457EAA-92AF-4A86-B89C-454977547F69Q37010188-7540C1B1-42A3-47A6-99E9-DA4C3528CE8BQ37092913-3A650A0E-974A-4496-A2A1-85BDA939D55BQ37126227-7FB76077-D738-4340-AC9B-A6F1B88DE435Q37142138-A712B9BB-8208-4831-AED6-ACFF08B63FDBQ37176066-444B13BE-D8CF-4E0F-98BE-85F73DA24C6BQ37267184-E568AE33-6655-44F8-9E44-EB1AF0AF12CDQ37278858-1D37BB99-9681-495D-8355-E1F082E4980CQ37651124-249AC7D0-7F83-41D0-AB54-486BA545138EQ37677252-D4373DF2-CD73-4C2C-99F4-945C807431D1Q37821269-438E56FC-4222-44EB-8AF2-0551BF604DC4
P2860
Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Beyond peroxisome proliferator ...... effect of thiazolidinediones.
@ast
Beyond peroxisome proliferator ...... effect of thiazolidinediones.
@en
type
label
Beyond peroxisome proliferator ...... effect of thiazolidinediones.
@ast
Beyond peroxisome proliferator ...... effect of thiazolidinediones.
@en
prefLabel
Beyond peroxisome proliferator ...... effect of thiazolidinediones.
@ast
Beyond peroxisome proliferator ...... effect of thiazolidinediones.
@en
P2093
P356
P1476
Beyond peroxisome proliferator ...... effect of thiazolidinediones.
@en
P2093
P304
P356
10.1677/ERC.1.01182
P577
2006-06-01T00:00:00Z